Mitochondrial pathology in Parkinson's disease and implications for therapeutic intervention

被引:0
|
作者
Swerdlow, RH [1 ]
Parker, WD [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22908 USA
关键词
mitochondria; Parkinson's disease; mitochondrial DNA; therapy;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although the ultimate origin and role of mitochondrial pathology in Parkinson's disease (PD) remains controversial, accumulating data suggest that mitochondrial dysfunction is genetic and plays an important role in neurodegeneration. PD mitochondria display abnormal electron transport chain activity, increased reactive oxygen species generation, and abnormal calcium handling. These abnormalities arise, at least in part, from information encoded by mitochondrial DNA. These processes are implicated in current models of neuronal death and validate ongoing efforts to develop mitochondrial-level pharmacologic interventions for the treatment of this disease. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:44 / 50
页数:7
相关论文
共 50 条
  • [31] Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
    Zaltieri, Michela
    Longhena, Francesca
    Pizzi, Marina
    Missale, Cristina
    Spano, PierFranco
    Bellucci, Arianna
    PARKINSONS DISEASE, 2015, 2015
  • [32] Parkinson's disease: pathology
    Goetz, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S127 - S127
  • [33] The pathology of Parkinson's disease
    Jellinger, KA
    PARKINSON'S DISEASE, 2001, 86 : 55 - 72
  • [34] Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease
    Yao, Meng-Fan
    Dang, Tao
    Wang, Hua-Jun
    Zhu, Xiao-Zhong
    Qiao, Chen
    BEHAVIOURAL BRAIN RESEARCH, 2024, 459
  • [35] Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease
    Prasuhn, Jannik
    Brueggemann, Norbert
    GENES, 2021, 12 (11)
  • [36] Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinson's Disease
    Arduino, D. M.
    Esteves, A. R.
    Oliveira, C. R.
    Cardoso, S. M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (01) : 105 - 119
  • [37] Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson?s Disease
    Tryphena, Kamatham Pushpa
    Nikhil, Uppala Sai
    Pinjala, Poojitha
    Srivastava, Saurabh
    Singh, Shashi Bala
    Khatri, Dharmendra Kumar
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (08): : 1356 - 1368
  • [38] Mitochondrial Respiratory Chain Dysfunction -A Hallmark Pathology of Idiopathic Parkinson's Disease?
    Flones, Irene H.
    Tzoulis, Charalampos
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [39] Parkinson's disease pathology and vascular pathology contribute to the development of Parkinson's disease dementia
    Rosenthal, L. S.
    Troncoso, J. C.
    Pletnikova, O.
    Bassett, S. S.
    Pontone, G. M.
    Mari, Z.
    Dawson, T. M.
    MOVEMENT DISORDERS, 2014, 29 : S361 - S361
  • [40] Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease
    Mueller, Sarina K.
    Bender, Andreas
    Laub, Christoph
    Hoegen, Tobias
    Schlaudraff, Falk
    Liss, Birgit
    Klopstock, Thomas
    Elstner, Matthias
    NEUROBIOLOGY OF AGING, 2013, 34 (09) : 2231 - 2233